Article
Variant diphtheria toxin-interleukin-3 fusion proteins with increased receptor affinity have enhanced cytotoxicity against acute myeloid leukemia progenitors.
Clinical cancer research : an official journal of the American Association for Cancer Research - 15 Feb 2006
Hogge Donna E, Yalcintepe Leman, Wong Siaw-Hui, Gerhard Brigitte, Frankel Arthur E
Abstract excerpt
A fusion protein linking a truncated form of diphtheria toxin (DT(388)) to human interleukin-3 (DT(388)IL3) kills malignant progenitors from some patients with acute myeloid leukemia (AML) while sparing normal progenitors. This study evaluated two variants of DT(388)IL3 with increased affinity for the IL-3 receptor (IL-3R) for their cytotoxicity to AML progenitors and determined the ability of quantitative...
Topics
- Adolescent
- Adult
- Aged
- Cell Survival
- Diphtheria Toxin
- Dose-Response Relationship, Drug
- Female
- Gene Expression
- Humans
- Interleukin-3
